IGMS - IGM Biosciences GAAP EPS of -$0.83 misses by $0.01 revenue of $0.5M misses by $0.28M
2024-05-09 12:44:06 ET
More on IGM Biosciences
- IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points
- IGM Biosciences announces refocusing of Sanofi collaboration
- IGM Biosciences GAAP EPS of -$1.01 beats by $0.08, revenue of $0.7M misses by $0.07M
- Seeking Alpha’s Quant Rating on IGM Biosciences
- Historical earnings data for IGM Biosciences